ArfGAP with SH3 domain, ankyrin repeats, and PH domain 1 (ASAP1) is associated with poor survival in breast cancer, while it has also been reported that the loss of ASAP1 in luminal breast cancer accelerates tumorigenesis and promotes metastasis by activating AKT 49. Here, AKT1 is linked to breast carcinoma.